Ophthalmic Drug Market

The ophthalmic drug market encompasses medications for treating a range of eye diseases such as cataracts, glaucoma, and diabetic retinopathy. Key customers are patients with these conditions, served through healthcare providers and systems. The market's growth is primarily driven by an increasing global elderly population, a rising prevalence of eye diseases like glaucoma, and higher overall healthcare spending on ocular health.